Literature DB >> 19400270

Synthesis and pharmacological evaluation of highly potent [Dmt1]DALDA analogs.

P Anantha Reddy1, Anita H Lewin, Peter W Schiller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19400270      PMCID： PMC2720553          DOI： 10.1007/978-0-387-73657-0_203

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

1.  Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.

Authors:  P W Schiller; T M Nguyen; N N Chung; C Lemieux
Journal:  J Med Chem       Date:  1989-03       Impact factor: 7.446

2.  Synthesis and in vitro opioid activity profiles of DALDA analogues.

Authors:  P W Schiller; T M Nguyen; I Berezowska; S Dupuis; G Weltrowska; N N Chung; C Lemieux
Journal:  Eur J Med Chem       Date:  2000-10       Impact factor: 6.514

3.  Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury.

Authors:  Kesheng Zhao; Guo-Min Zhao; Dunli Wu; Yi Soong; Alex V Birk; Peter W Schiller; Hazel H Szeto
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

4.  A synthetic analogue for the active site of plant-type ferredoxin: two different coordination isomers by a four-cys-containing [20]-peptide.

Authors:  N Ueyama; S Ueno; A Nakamura; K Wada; H Matsubara; S Kumagai; S Sakakibara; T Tsukihara
Journal:  Biopolymers       Date:  1992-11       Impact factor: 2.505

5.  Highly potent fluorescent analogues of the opioid peptide [Dmt1] DALDA.

Authors:  Irena Berezowska; Nga N Chung; Carole Lemieux; Bogumil Zelent; Hazel H Szeto; Peter W Schiller
Journal:  Peptides       Date:  2003-08       Impact factor: 3.750

6.  Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.

Authors:  Guo-Min Zhao; Dunli Wu; Yi Soong; Megumi Shimoyama; Irena Berezowska; Peter W Schiller; Hazel H Szeto
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030
  6 in total
  1 in total

1.  Multiple Target Drug Design Using LigBuilder 3.

Authors:  Xiaoyu Qing; Shiwei Wang; Yaxia Yuan; Jianfeng Pei; Luhua Lai
Journal:  Methods Mol Biol       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.